Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
9.31
Oct 30 • 3:59 PM ET Dollar change-0.09 Percentage change(-0.96%)
Aftermarket Close
9.36
Aftermarket • 7:30 PM ET Dollar change+0.05 Percentage change(0.54%)
Index
-
Market Cap
5.20B
Enterprise Value
47.54B
Income
358.27M
Sales
6.29B
Book/sh
12.51
Cash/sh
4.39
Employees
7240
IPO
May 02, 2013
P/E
14.79
Forward P/E
3.94
PEG
2.36
P/S
0.83
P/B
0.74
P/C
2.12
P/FCF
-
EV/EBITDA
15.26
EV/Sales
7.56
Quick Ratio
0.66
Current Ratio
0.28
Debt/Eq
4.90
LT Debt/Eq
2.72
Option/Short
Yes / Yes
EPS (ttm)
0.63
EPS next Y
2.37
EPS next Q
0.70
EPS this Y
-0.75%
EPS next Y
1.41%
EPS next 5Y
1.67%
EPS past 3/5Y
-16.68% -
Sales past 3/5Y
50.47% 31.34%
EPS Y/Y TTM
-56.25%
Sales Y/Y TTM
26.36%
EPS Q/Q
8.17%
Sales Q/Q
33.18%
Insider Own
0.51%
Insider Trans
-3.24%
Inst Own
61.61%
Inst Trans
-2.12%
ROA
0.96%
ROE
5.71%
ROIC
1.55%
Gross Margin
88.95%
Oper. Margin
44.52%
Profit Margin
5.69%
SMA20
5.66%
SMA50
0.02%
SMA200
-4.09%
Trades
Shs Outstand
558.41M
Shs Float
555.57M
52W High
12.15 -23.34%
52W Low
8.31 12.03%
Volatility
2.29% 2.80%
ATR (14)
0.26
RSI (14)
56.52
Beta
1.17
Rel Volume
1.05
Avg Volume
6.05M
Volume
6,332,744
Perf Week
-0.85%
Perf Month
6.40%
Perf Quarter
-7.46%
Perf Half Y
-4.90%
Perf YTD
-14.59%
Perf Year
-15.29%
Perf 3Y
1.20%
Perf 5Y
-12.78%
Perf 10Y
-28.82%
Prev Close
9.40
Price
9.31
Change %
-0.96%
Consensus
Strong Buy
Avg. Price Target
$12.80
Implied Upside
+37.5%
Analysts4incl. previous ratings
Rating Distribution4 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jun 08, 2026Initiated
CCompass Point
Buy$14+50.4%
Jan 08, 2026Resumed
UBS logoUUBS
Buy$16+71.9%
Apr 28, 2025Upgrade
PPiper Sandler
Neutral → Overweight$14+50.4%
Dec 06, 2023Initiated
UBS logoUUBS
Buy$12.50+34.3%
Dec 16, 2022Initiated
RILY logoRB. Riley Securities
Buy$12+28.9%
Sep 30, 2022Upgrade
PPiper Sandler
Underweight → Neutral$10 → $9-3.3%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hebard Peggy HwanDirectorAug 20 '26Sale10.1814,520147,74182,259Aug 25 04:32 PM
Hebard Peggy HwanDirectorAug 19 '26Proposed Sale10.3414,520150,122Aug 19 03:02 PM
David ZeidenFormer AffiliateAug 07 '26Proposed Sale9.949,21791,617Aug 07 05:33 PM
Saltzman DavidDirectorMay 20 '26Sale9.2580,922748,34644,248May 22 04:18 PM
David SaltzmanAffiliateMay 20 '26Proposed Sale9.0080,922728,298May 20 05:18 PM
Zeiden DavidChief Legal OfficerFeb 27 '26Option Exercise0.009,21709,217Mar 03 05:16 PM
Zeiden DavidChief Legal OfficerFeb 27 '26Sale10.119,21793,1560Mar 03 05:16 PM
David ZeidenAffiliateFeb 27 '26Proposed Sale10.2218,434188,395Feb 27 05:30 PM
Zeiden DavidChief Legal OfficerNov 14 '25Option Exercise0.0019,285019,285Nov 18 04:40 PM
Zeiden DavidChief Legal OfficerNov 14 '25Sale11.1119,285214,1600Nov 18 04:40 PM
David ZeidenAffiliateNov 14 '25Proposed Sale11.1519,285215,028Nov 14 04:40 PM
Nierenberg MichaelChief Executive OfficerNov 05 '25Sale11.00301,5483,316,0930Nov 06 05:26 PM
Michael NierenbergAffiliateNov 05 '25Proposed Sale10.99301,5483,314,012Nov 05 04:04 PM
Rithm Capital Corp. engages in the provision of real estate, credit, and financial services. It operates through the following segments: Origination and Servicing, Investment Portfolio, Residential Transitional Lending, Asset Management, and Corporate. The Origination and Servicing segment includes residential mortgage loans underlying mortgage servicing right assets as well as those sub-service for third parties. The Investment Portfolio segment consists of residential mortgage loans, SFR properties, consumer loans, Non-Agency RMBS, Excess MSRs and servicer advance investments. The Residential Transitional Lending segment competes for both experienced sponsors, including developers and investors in residential real estate, and attractive lending opportunities based on several factors. The Asset Management segment focuses on the wholly owned subsidiaries, Sculptor, and RCM Manager. The company was founded on September 26, 2011 and is headquartered in New York, NY.
ChairmanMr. Michael B. Nierenberg
CPAMr. Nicola Santoro Jr.
MD & Head of InvestmentsMr. Charles Sorrentino
Head of Investor RelationsMs. Ann Park DeVries
Chief Legal Officer & SecretaryMr. Philip Matthew Sivin C.F.A.